Global Archives – Page 7 of 25 – Treatment Action Group

1 / 4 / 6 x 24

March 13, 2023
Dorrit Walsh

Inspired by the legacy of Dr. Paul Farmer, the 1 / 4 / 6 x 24 Campaign calls for the “staff, stuff, space, systems and support” necessary to make groundbreaking short-course TB prevention and treatment regimens accessible to all who need them as a human right by the end of 2024.

Call for Expression of Interest: Community Advisory Boards to Support Community Engagement in Research under the SMART4TB Project

February 24, 2023
Dorrit Walsh

The SMART4TB Consortium is calling for expressions of interest from multi-national community advisory boards (CAB) or similarly organized civil society organizations within three geographic focus areas to support community engagement in research in a new five-year research project funded by USAID.

CROI 2023 Tuberculosis Research Round Up

February 22, 2023
Dorrit Walsh

Treatment Action Group (TAG) welcomes the tuberculosis (TB) data presented at the 2023 Conference on Retroviruses and Opportunistic Infections (CROI).

TB Treatment Trial Results in Context for Communities

February 17, 2023
Dorrit Walsh

On Tuesday, March 14 at 8:00 am ET, join Treatment Action Group (TAG) and Dr. Jennifer Furin for an overview of key results and breakdown of how they fit into the larger TB policy and research landscapes.

2023 CROI Community HIV Cure Research Workshop

2023 Pre-CROI Community HIV Cure Research Workshop

February 10, 2023
Dorrit Walsh

The 2023 Pre-CROI Community HIV Cure Research Workshop will be held on Saturday, February 18th in the Sequoia Glacier Room at Crowne Plaza Hotel, 1113 - 6th Avenue, Seattle, WA 98101.

Advocating for the Integration of Viral Hepatitis Prevention and Treatment for People Who Use Drugs in PEPFAR COPs

January 20, 2023
Dorrit Walsh

On January 24, 2022, Treatment Action Group (TAG), World Hepatitis Alliance (WHA), Harm Reduction International (HRI), the International Network of People Who Use Drugs (INPUD), and the International Drug Policy Consortium (IDPC) will host a webinar, “Advocating for the Integration of Viral Hepatitis Prevention and Treatment for People Who Use Drugs in PEFPFAR COPs."

Risk of Breakthrough COVID-19 Infections and Disease in Vaccinated People with HIV

December 15, 2022
Dorrit Walsh

This fact sheet on breakthrough COVID-19 infections among people living with HIV was co-produced by TAG and our partners the Black AIDS Institute, Southern AIDS Coalition and the COVID-19 Prevention Network.

2022 TAG Update

December 8, 2022
Dorrit Walsh

As we look forward to an end of an extremely challenging year—and past four years—we reflect on the remarkable resilience and impact of TAG, even and especially in these dark times.

publication cover, which reads: tuberculosis research funding trends, 2005 - 2021. Cover is blue with "$1 BILLION" in text over various monetary signs from different countries. Logos at bottom are StopTBPartnership and TAG

2022 Report on TB Research Funding Trends

December 6, 2022
Dorrit Walsh

For the first time in history, funding for tuberculosis (TB) research and development (R&D) hit a billion dollars worldwide in 2021.

Response to Tuberculosis Treatment Trials Results Published and Presented During the 2022 Union World Conference on Lung Health

November 16, 2022
Dorrit Walsh

Treatment Action Group (TAG) and the Global Tuberculosis Community Advisory Board (TB CAB) welcome the clinical trials results recently published and presented during the 2022 Union World Conference on Lung Health, which evaluated shorter regimens and treatment shortening strategies for drug-sensitive and drug-resistant tuberculosis.